3908 results for «2023»
3908 results
CTO PCI: an evolving landscape
21 May 2026 – From EuroPCR 2026
Review the evolving landscape of chronic total occlusion (CTO) PCI with a focus on recent trends, contemporary management in multivessel disease, and innovative techniques such as retrograde approaches and titrated contrast recanalization. This session also addresses cost-effectiveness and drug-coated balloon (DCB) therapy outcomes from multicenter studies.
Overcoming complications with intracoronary imaging
21 May 2026 – From EuroPCR 2026
Explore challenging cases of intracoronary imaging complications, highlighting recognition, management, and resolution of complex vascular and mechanical issues encountered during coronary interventions.
Sealing the deal: catheter based solutions for aortic disease
21 May 2026 – From EuroPCR 2026
Examine catheter-based solutions for aortic disease management, featuring innovative approaches to preserving branch vessels, managing vascular complications, and repairing challenging aneurysms with endografts and occluders.
Best complications on calcified lesions
20 May 2026 – From EuroPCR 2026
Highlighting challenging cases in calcified coronary lesions, this session presents a series of complications including stuck wires, the Kokeshi phenomenon, and multiple complications within a single vessel. It provides practical insights into rescue techniques and navigating complex procedural challenges.
How to obtain a surgical-liked result in a patient with primary mitral regurgitation?
20 May 2026 – From EuroPCR 2026
This session delves into achieving surgical-like outcomes in patients with primary mitral regurgitation undergoing transcatheter edge-to-edge repair (TEER). It covers anatomical criteria for optimal patient selection, essential procedural steps including device choice and imaging guidance, and key factors contributing to durable success and patient improvement.
Antithrombotic strategies in challenging clininal scenarios
21 May 2026 – From EuroPCR 2026
This session presents a comprehensive overview of antithrombotic strategies tailored to challenging clinical scenarios. Topics include management in elderly patients with atrial fibrillation undergoing DES implantation, the use of low-dose Cangrelor and Bivalirudin during PCI under ECMO in cardiac arrest, polymer types in stents, and timing...
TAVI complications: the nurses and allied professionals' perspective
20 May 2026 – From EuroPCR 2026
This session highlights the critical role nurses and allied professionals (NAPs) play during TAVI complications. Through detailed clinical cases, it emphasizes their contributions in managing adverse events and explores the significance of structured debriefing to enhance team performance and patient outcomes.
Complication two: PCI complications occurring during PCI for NSTEMI
21 May 2026 – From EuroPCR 2026
This session addresses the spectrum of PCI complications encountered during NSTEMI interventions, including coronary perforations, challenges with unexpanded covered stents, IVUS-related issues, giant coronary aneurysms at bifurcations, and distal wire perforations, providing critical lessons in complication management and operator coordination.
TAVI procedural complications - Part 6: paravalvular leak, basilica and more
20 May 2026 – From EuroPCR 2026
Delve into complex TAVI procedural complications including paravalvular leak and challenges such as BASILICA technique failures, aortic dissection, valve infolding, and valve dislocation. This session presents real-world cases illustrating troubleshooting strategies and innovative interventions like TAVI-in-TAVI procedures to address these critical scenarios.
New insights in coronary atherosclerosis using intracoronary imaging
21 May 2026 – From EuroPCR 2026
This session provides new insights into coronary atherosclerosis through intracoronary imaging studies. It investigates the relationship between Lp(a) levels and high-risk plaques, characteristics of vulnerable plaques and thrombus in ACS, non-culprit lesion events, lipid core burden in STEMI, and the prognostic value of AI-derived lipid-to-cap ratios,...
Intracoronary imaging insights in ACS
20 May 2026 – From EuroPCR 2026
Discover how intracoronary imaging advances understanding and management of acute coronary syndromes (ACS). This session explores high-definition intravascular ultrasound for PCI guidance, novel predictive metrics, and the impact of emerging factors like microplastics on plaque instability, alongside pathophysiological insights into layered plaques and coronary ectasia in...
Increasing efficiency in CTO PCI
21 May 2026 – From EuroPCR 2026
Focused on increasing efficiency in CTO PCI, this session covers diverse technical approaches including overcoming unexpected anatomical barriers, multiple wiring techniques, microchannel selection in bifurcation lesions, managing tortuous right coronary artery CTOs, unconventional strategies for uncrossable CTOs, and adapting perspectives in patients with previous CABG.
When atrial septal closure gets complex
21 May 2026 – From EuroPCR 2026
This session explores the complexities that arise when atrial septal closure procedures become challenging. It covers hybrid retrieval techniques for occluder devices, management of device-related complications mimicking infection, resolution of uncommon complications, and case studies including cryptogenic stroke management in athletes, highlighting procedural intricacies and solutions.
TAVI: LIVE Educational Case from Cleveland Clinic - London, UK
21 May 2026 – From EuroPCR 2026
This educational case session from the Cleveland Clinic focuses on lifetime management strategies for severe aortic stenosis, emphasizing optimal valve-in-valve (TAV-in-SAV) procedures. It covers patient assessment, valve selection, procedural techniques, and outcomes to guide management of degenerate surgical bioprostheses.
Challenging transcatheter interventions for mitral stenosis and mitral annular calcification
21 May 2026 – From EuroPCR 2026
This session addresses the challenges of transcatheter interventions in severe mitral stenosis and mitral annular calcification. It highlights therapeutic innovations such as treating mitral stenosis with annular calcification, valve-in-MAC procedures, use of extra-large Myval valves, transatrial ViMAC approaches, and combined multivalve interventions in rheumatic heart disease.
Adopting a step-by-step approach for successful redo TAVI
21 May 2026 – From EuroPCR 2026
This session outlines a systematic step-by-step approach for redo TAVI procedures, including detailed pre-procedural CT analysis. It addresses challenges associated with failing short and tall-frame valves, and discusses coronary protection and leaflet modification techniques critical for successful reinterventions.
Imaging-guided CTO PCI
21 May 2026 – From EuroPCR 2026
This session focuses on imaging-guided CTO PCI, presenting cases that illustrate the utility of OCT, CT, and IVUS for lesion assessment and procedural guidance. Topics include woven-like CTOs, double CTO evaluation, management of late stent malapposition, and strategies for navigating complex occlusions to optimize outcomes.
Innovation in transcatheter mitral valve interventions
21 May 2026 – From EuroPCR 2026
This comprehensive session presents the latest innovations in transcatheter mitral valve interventions, highlighting cutting-edge devices and clinical experiences. Topics include early feasibility studies of novel hemivalve systems, first-in-human experiences with new mitral valve replacement technologies, advances in transcatheter edge-to-edge repair (TEER) with one-year outcome data, and...
The impact of calcified and resistant lesions in clinical outcome of PCI
21 May 2026 – From EuroPCR 2026
Delve into the clinical implications of calcified and resistant coronary lesions on percutaneous coronary intervention (PCI) outcomes. This session presents key registry data and study results on intravascular lithotripsy and plaque modification techniques, highlighting their impact on patient prognosis and stent performance.
Insight from recent evidence in coronary artery disease: value of DCB for de novo lesions (SELUTION) and imaging for left main PCI (OPTIMAL)
21 May 2026 – From EuroPCR 2026
This session reviews pivotal recent evidence impacting daily practice in coronary artery disease management. It discusses the role of drug-coated balloons (DCB) for de novo lesions as evaluated in the SELUTION trial and evaluates intracoronary imaging strategies for left main PCI as presented in the OPTIMAL...